Stereotaxis, Inc. (STXS)
 NYSEAMERICAN: STXS · Real-Time Price · USD
 2.920
 0.00 (0.00%)
  Oct 30, 2025, 4:00 PM EDT - Market closed
Stereotaxis Revenue
Stereotaxis had revenue of $8.80M in the quarter ending June 30, 2025, with 95.42% growth. This brings the company's revenue in the last twelve months to $31.81M, up 33.94% year-over-year. In the year 2024, Stereotaxis had annual revenue of $26.92M with 0.55% growth.
Revenue (ttm) 
 $31.81M
Revenue Growth 
 +33.94%
P/S Ratio 
 8.00
Revenue / Employee 
 $228,820
Employees 
 139
Market Cap 
265.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 26.92M | 147.00K | 0.55% | 
| Dec 31, 2023 | 26.77M | -1.38M | -4.89% | 
| Dec 31, 2022 | 28.15M | -6.87M | -19.63% | 
| Dec 31, 2021 | 35.02M | 8.39M | 31.51% | 
| Dec 31, 2020 | 26.63M | -2.27M | -7.86% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| UnitedHealth Group | 435.16B | 
| Johnson & Johnson | 92.15B | 
| Merck & Co. | 64.24B | 
| Eli Lilly and Company | 59.42B | 
| AbbVie | 58.33B | 
| AstraZeneca | 56.50B | 
| Novartis AG | 56.37B | 
| Novo Nordisk | 49.11B | 
STXS News
- 9 days ago - Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025 - GlobeNewsWire
- 15 days ago - Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs - GlobeNewsWire
- 17 days ago - Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias - GlobeNewsWire
- 5 weeks ago - Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System - GlobeNewsWire
- 2 months ago - First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter - GlobeNewsWire
- 2 months ago - Stereotaxis to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025 - GlobeNewsWire
- 2 months ago - Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript - Seeking Alpha